Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05384860 · ClinicalTrials.gov registry record · NA
Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery
A NA study of Opioid Use and Acupuncture, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 484
- Enrollment target
- 1
- Study location
NCT05384860 is a NA study of Opioid Use and Acupuncture that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 484 participants, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05384860, a NA study of Opioid Use and Acupuncture, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 484 participants
- Enrollment target
- 1
- Study location
Study Summary
At this time, no formal ERAS (enhanced recovery after surgery) protocol exists for THR that incorporates perioperative acupuncture. Developing, and more importantly, validating a preliminary fast-track protocol for THR can have a significant impact on reducing recovery time and improving the rate at which this subgroup of surgeries is done on an outpatient basis. Furthermore, previous studies of acupuncture as an adjunctive therapy for postoperative analgesia have primarily investigated patient satisfaction rather than the impact on postoperative opioid consumption. The majority of studies also place acupuncture needles preoperatively, rather than following induction of anesthesia (intra-operatively). This study hopes to show that placing auricular therapy needles intraoperatively is a feasible part of a protocol for motivated patients to minimize opioids after total knee arthroplasty. The prospect of incorporating intraoperative acupuncture as an adjunct into said protocol is very attractive given its low cost, its safety profile, its ease of administration, and the growing evidence supporting its efficacy. This study would provide further clarity on whether perioperative acupuncture can effectively reduce hospital length of stay and post-operative opioid consumption, in addition to evaluating the role of perioperative acupuncture in improving recovery after THR as part of a multimodal fast-track protocol.
Conditions Studied
Interventions
- DEVICE Auricular Trauma Protocol (ATP) Acupuncture
- OTHER No Acupuncture Group
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 484 participants |
| Start Date | 2022-07-06 |
| Est. Completion | 2025-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05384860
The ClinicalTrials.gov registry entry for NCT05384860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 484 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Auricular Trauma Protocol (ATP) Acupuncture is the first listed.
NCT05384860 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05384860 about?
NCT05384860 is a clinical study titled "Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery". At this time, no formal ERAS (enhanced recovery after surgery) protocol exists for THR that incorporates perioperative acupuncture. Developing, and more importantly, validating a preliminary fast-track protocol for THR can have a significant impact on reducing recovery time and improving the rate at...
What is the current status of trial NCT05384860?
This trial is currently completed. It is a NA study. The enrollment target is 484 participants. The study started on 2022-07-06. Estimated completion is 2025-04-04.
What conditions does trial NCT05384860 study?
This clinical trial studies the following conditions: Opioid Use, Acupuncture, Hip Surgery.
What interventions are being tested in trial NCT05384860?
The interventions under investigation include: Auricular Trauma Protocol (ATP) Acupuncture (DEVICE), No Acupuncture Group (OTHER).
Who is sponsoring clinical trial NCT05384860?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05384860 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.